Frag' FlorenceEvidenz. Klar. Anwendbar.
Uhr 7/8Sources Journal Tree
Easy Demo

Lokaler Crossref-Datenbestand · journal-article

10.3390/polym8030084

CrossRef Listing of Deleted DOIs · 2000

Vollständiger Abstract

Worum geht es in dieser Arbeit?

<i>Background and Objectives:</i> Evidence regarding continuation versus withdrawal of immunosuppressive agents during antiviral treatment of cytomegalovirus (CMV) colitis complicating ulcerative colitis (UC) remains limited. We compared molecular remission, clinical outcomes, and relapse according to immunosuppressive-therapy management. <i>Materials and Methods:</i> This prospective, non-randomized, single-center cohort included 44 hospitalized adults with UC and CMV colitis treated with intravenous ganciclovir. Patients were managed according to a clinician-selected strategy of temporary discontinuation (<i>n</i> = 24) or continuation (<i>n</i> = 20) of immunosuppressive therapy. Molecular remission, the primary outcome, was defined as undetectable tissue CMV DNA at day 14. <i>Results:</i> Both groups demonstrated significant clinical and endoscopic improvement. The continuation group had higher residual CMV DNA levels at day 14 (<i>p</i> = 0.003) and more adverse events (<i>p</i> = 0.019). Clinical remission, endoscopic remission, and one-year relapse rates were comparable. Multivariable logistic regression showed that continuation of immunosuppressive therapy was associated with reduced molecular remission (OR 0.26, 95% CI 0.07-0.98; <i>p</i> = 0.045). Corticosteroid exposure was confined to the continuation group (7/20 vs. 0/24), raising the possibility of substantial residual confounding. <i>Conclusions:</i> In this exploratory cohort, clinician-selected continuation of immunosuppressive therapy was associated with a lower likelihood of day-14 molecular remission and more frequent adverse events, without demonstrable additional clinical or endoscopic benefit. However, the observed association may have been influenced by corticosteroid exposure and should not be interpreted as a class-wide effect of immunosuppressive therapy. These hypothesis-generating findings require confirmation in adequately powered multicenter studies before informing routine clinical practice.

Abstract: PubMed · Datensatz

Bibliografischer Nachweis

Publikationsdaten

Autor:innen
Nicht angegeben
Quelle
CrossRef Listing of Deleted DOIs
Publikation
2000-01-01
Band / Ausgabe
Nicht angegeben
Seiten
Nicht angegeben
ISSN / ISBN
0849-6757
Zitationen
0 laut Crossref
Referenzen
0 hinterlegt

Zitieren

Zitierfähiger Nachweis

(2000). 10.3390/polym8030084. CrossRef Listing of Deleted DOIs. https://doi.org/10.3390/medicina62081532
RIS BibTeX CSL-JSON